Opdivo and Yervoy
Learn everything you need to know about Opdivo and Yervoy, the latest mesothelioma treatment approved by the U.S. Food and Drug Administration. In our online presentation, mesothelioma patients and loved ones will discover the benefits of the chemo-free immunotherapy combination, differences between other immunotherapies and who is eligible. Get your free recording today!
Learn about Opdivo and Yervoy. Hosts Dr. Snehal Smart & Registered Nurse Karen Selby discuss the benefits, differences and eligibility. Get your free recording now!
Snehal Smart, M.D.Medical Advisor
Karen Selby, RNRegistered Nurse
Or Fill Out Our Form:
Sign Up to Get a Free Recording
Information Covered in Opdivo and Yervoy Webinar
- Opdivo and Yervoy clinical trial results & survival benefits
- Differences between immunotherapy & chemotherapy
- How the immunotherapy combination works & side effects
- Talking to your doctor about prescribing Opdivo and Yervoy
- What to expect during a treatment visit
- Complement therapies & other options after Opdivo and Yervoy
You’ll also get access to the free Q&A session that our experts hosted after the presentation.
Learn from the Top Mesothelioma Experts
Snehal Smart, M.D.Dr. Snehal Smart is an experienced Patient Advocate and an expert medical writer. When she is not providing one-on-one assistance to patients, Smart stays current on the latest medical research, reading peer-reviewed studies and interviewing oncologists to learn about advancements in diagnostic tools and cancer treatments.
Karen Selby, RNAs a registered nurse with decades of experience in thoracic surgery, Karen Selby has assisted doctors in lung resections, lung transplants and other complicated lung-related surgeries. In her role as a Patient Advocate, she listens and guides mesothelioma patients and their caregivers every day.
Sean Marchese, RNAs a registered nurse with more than 10 years in clinical experience, including pain management, Sean Marchese has planned and led experimental clinical trials in oncology involving immunotherapy, chemotherapy, radiation therapy and tumor treating fields. He has been a member of the American Nurses Association since 2017.